
Charles River Laboratories International CRL
€ 164.02
-0.96%
Quartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Land |
|
IPO-Jahr |
2000 |
Branche |
Diagnostik & Forschung |
Börse |
NYSESPB |
Anteile |
51.4 M |
Marktkapitalisierung |
$ 9.89 B |
EBITDA (LTM) |
$ 839 M |
P/E (LTM) |
48.52 |
P/S (LTM) |
2.48 |
EPS (LTM) |
4.01 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Castle Biosciences
CSTL
|
$ 38.85 | 2.32 % | $ 1.08 B | Nasdaq Global Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 16.36 | -4.05 % | $ 176 M | Nasdaq Global Market | ||
|
Brainsway Ltd.
BWAY
|
$ 17.05 | -2.15 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Danaher Corporation
DHR
|
$ 227.08 | -2.28 % | $ 166 B | NYSE,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.58 | 0.21 % | $ 18.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 27.13 | 0.26 % | $ 820 M | Nasdaq Global Market | ||
|
BioNano Genomics
BNGO
|
$ 1.63 | -2.11 % | $ 2.07 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 66.91 | -2.94 % | $ 25.8 B | Nasdaq Global Select Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 11.92 | -6.58 % | $ 338 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 134.29 | -1.58 % | $ 21.4 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 221.54 | -1.96 % | $ 40.2 B | NYSE,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 66.11 | 4.76 % | $ 4.57 B | Nasdaq Global Select Market,SPB | ||
|
Guardant Health
GH
|
$ 102.09 | 0.7 % | $ 12.5 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 20.44 | 3.23 % | $ 1.1 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 105.26 | 4.46 % | $ 4.15 B | Nasdaq Global Select Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.59 | -25.21 % | $ 115 K | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 0.34 | -2.96 % | $ 9.98 M | Nasdaq Capital Market | ||
|
Myriad Genetics
MYGN
|
$ 7.26 | -0.62 % | $ 658 M | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 6.86 | -2.63 % | $ 1.49 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 17.81 | 2.24 % | $ 437 M | Nasdaq Global Select Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 263.51 | -0.46 % | $ 22.1 B | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.13 | -1.61 % | $ 540 M | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.6 | -1.52 % | $ 20 B | NYSE | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 28.79 | -2.93 % | $ 1.21 B | Nasdaq Global Select Market,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
RadNet
RDNT
|
$ 75.0 | -4.65 % | $ 5.48 B | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 182.21 | 0.35 % | $ 20.2 B | NYSE,SPB | ||
|
Biodesix
BDSX
|
$ 7.94 | -1.0 % | $ 1.03 B | Nasdaq Global Market | ||
|
ICON Public Limited Company
ICLR
|
$ 186.28 | -1.92 % | $ 15.4 B | Nasdaq Global Select Market,SPB |